ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 13

$431K Total Retail Price of All Prescriptions

Rank: 3 out of 13

572 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 572 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

5% of this provider’s 572 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 896 711 1 1
SIMVASTATIN 663 558 2 2
LISINOPRIL 561 489 3 5
OMEPRAZOLE 475 331 4 3
HYDROCHLOROTHIAZIDE 433 392 5 10
ATENOLOL 425 356 6 12
TRAMADOL HCL 283 176 7 14
WARFARIN SODIUM 264 194 8 7
FUROSEMIDE 262 224 9 4
METFORMIN HCL 259 194 10 5
METOPROLOL TARTRATE 230 214 11 8
AZITHROMYCIN 220 168 12 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 163 13 47
GLIPIZIDE 175 139 14 69
ALENDRONATE SODIUM 164 153 15 24
CITALOPRAM HBR 159 144 16 15
CIPROFLOXACIN HCL 159 125 16 33
AMLODIPINE BESYLATE 149 144 18 9
ATORVASTATIN CALCIUM 142 114 19 19
METOPROLOL SUCCINATE 133 101 20 21
POTASSIUM CHLORIDE 131 114 21 13
DICLOFENAC SODIUM 130 73 22 48
ENALAPRIL MALEATE 125 107 23 23
SERTRALINE HCL 123 110 24 36
ZOLPIDEM TARTRATE 105 83 25 27
RANITIDINE HCL 101 68 26 28
GABAPENTIN 100 53 27 16
LOVASTATIN 98 81 28 34
KLOR-CON 10 96 87 29 76
LOSARTAN POTASSIUM 90 83 30 25
FLUOXETINE HCL 89 62 31 45
CEPHALEXIN 88 60 32 53
PROAIR HFA 88 64 32 39
PAROXETINE HCL 79 66 34 31
LOSARTAN-HYDROCHLOROTHIAZIDE 79 79 34 76
HYDROCODONE-ACETAMINOPHEN 78 39 S3 36 11
CYCLOBENZAPRINE HCL 76 17 R 37 42
NAMENDA 74 74 38 54
PRAMIPEXOLE DIHYDROCHLORIDE 68 56 39 83
GLIPIZIDE XL 67 57 40 115
FLUTICASONE PROPIONATE 63 53 41 37
PRAVASTATIN SODIUM 62 53 42 18
TRIAMTERENE-HCTZ 62 58 42 20
LANSOPRAZOLE 61 58 44 122
DILTIAZEM ER 60 60 45 89
LANTUS 59 43 46 43
CRESTOR 58 45 47 49
AMITRIPTYLINE HCL 57 30 R 48 55
ALLOPURINOL 57 54 48 22
NIFEDIPINE ER 56 56 50 95
TERAZOSIN HCL 56 56 50 84
CELEBREX 54 40 52 51
GEMFIBROZIL 51 48 53 138
OXYBUTYNIN CHLORIDE 50 43 54 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.